BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15344981)

  • 1. Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
    Batra A; Tripathi RP; Singh AK
    Australas Radiol; 2004 Sep; 48(3):324-32. PubMed ID: 15344981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
    Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
    Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
    Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
    NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
    Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
    Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
    Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
    Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
    Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
    AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
    Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC
    AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management].
    Metellus P; Dutertre G; Mekkaoui C; Nanni I; Fuentes S; Ait-Ameur A; Chinot O; Dufour H; Figarella-Branger D; Cordoliani YS; Grisoli F
    Neurochirurgie; 2008 Aug; 54(4):503-11. PubMed ID: 18573509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
    Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
    J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.
    Hermann EJ; Hattingen E; Krauss JK; Marquardt G; Pilatus U; Franz K; Setzer M; Gasser T; Tews DS; Zanella FE; Seifert V; Lanfermann H
    Stereotact Funct Neurosurg; 2008; 86(5):300-7. PubMed ID: 18791331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
    Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
    Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.